Tricyclic compounds
USRE47221E1 · kind E1 · reissue
40Cited by
26References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 1, 2017 |
| Grant date | Feb 5, 2019 |
| Priority date | — |
| Expiry date | Mar 1, 2037 |
Classification
- Technology area (CPC —)General
Abstract
The invention provides compounds of Formula (I) and Formula (II) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.